Urteste S.A. (WSE:URT)
Poland · Delayed Price · Currency is PLN 37.80
+2.80 (8.00%)
At close: Dec 5, 2025
Urteste Revenue
Urteste had revenue of 712.00K PLN in the quarter ending September 30, 2025, with 962.69% growth. This brings the company's revenue in the last twelve months to 2.65M, up 13.16% year-over-year. In the year 2024, Urteste had annual revenue of 1.80M with 35.34% growth.
Revenue (ttm)
2.65M
Revenue Growth
+13.16%
P/S Ratio
29.60
Revenue / Employee
54.55K
Employees
20
Market Cap
53.29M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.80M | 470.00K | 35.34% |
| Dec 31, 2023 | 1.33M | 1.33M | 44,233.33% |
| Dec 31, 2022 | 3.00K | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| NEUCA | 13.34B |
| Diagnostyka | 2.30B |
| Centrum Medyczne ENEL-MED | 820.59M |
| Synektik Spólka Akcyjna | 623.20M |
| Voxel | 568.83M |
| Selvita | 373.90M |
| Celon Pharma | 225.60M |
| Ryvu Therapeutics | 90.41M |